T cell receptor beta variable 5-2 (TRBV5-2)

T cell receptor beta variable 5-2 (TRBV5-2) is a variable gene segment encoding the V region of the beta chain of the αβ T cell receptor (TCR), which is expressed on T lymphocytes and required for antigen recognition in adaptive immunity. The TCR recognizes peptides presented by major histocompatibility complex (MHC) molecules on antigen-presenting cells, triggering a signaling cascade—via the CD3 complex—that leads to T cell activation, proliferation, and effector function[2][3]. The beta chain variable region, including TRBV5-2, contributes to the antigen specificity of individual T cells through its unique complementarity-determining regions (CDRs), which are generated by somatic recombination[5]. Certain TRBV family members, including TRBV5, may be disproportionately expanded or used in particular immune responses (e.g., infections, malignancies)[4]. Recent advances demonstrate that single beta chain domains—including those encoded by TRBV5-2—can be engineered for therapeutic applications, such as TCR-based immune cell therapies or chimeric antigen receptor (CAR)-T constructs[1]. No drugs specifically inhibit TRBV5-2, but engineered T cells may exploit its specificity for cell-based therapy.

Other names

TRBV52TCRBV31S1TCRBV5S2P

Engages peptide-MHC complexes (pMHC) presented by antigen-presenting cells, leading to intracellular T-cell signaling and immune activation[2]. Next-generation immune therapies may exploit the specificity of variable domains such as TRBV5-2 for adoptive T cell engineering[1].